Morphological Biomarker Differentiating MCI Converters from Nonconverters: Longitudinal Evidence Based on Hemispheric Asymmetry

Behavioural Neurology
Xiaojing LongLijuan Zhang

Abstract

Identifying subjects with mild cognitive impairment (MCI) who may probably progress to Alzheimer's disease (AD) is important for better understanding the disease mechanisms and facilitating early treatments. In addition to the direct volumetric and thickness measurement based on high-resolution magnetic resonance imaging (MRI), hemispheric asymmetry could be a potential index to detect morphological variations in MCI patients with a high risk of conversion to AD. The present study collected a set of longitudinal MRI data from 53 MCI converters and nonconverters and investigated the asymmetry differences between groups. Asymmetry variation was observed in the medial temporal lobe, especially in the entorhinal cortex, between converters and nonconverters 3 years before the former developed AD. The proposed asymmetry analysis was observed to be sensitive to detect morphological changes between groups as compared to the methods of voxel-based morphometry (VBM) and thickness measurement. Hemispheric asymmetry in specific brain regions as a neuroimaging biomarker can provide helpful information for prediction of MCI conversion.

References

Jun 22, 2000·NeuroImage·J Ashburner, K J Friston
Jan 4, 2003·Nature Reviews. Neuroscience·Arthur W Toga, Paul M Thompson
Jun 26, 2004·Annual Review of Neuroscience·Larry R SquireRobert E Clark
Aug 18, 2004·Neurobiology of Aging·Leyla deToledo-MorrellD A Turner
Mar 24, 2005·Dementia and Geriatric Cognitive Disorders·Josephine BarnesNick C Fox
Feb 28, 2008·Journal of Magnetic Resonance Imaging : JMRI·Clifford R JackMichael W Weiner
Aug 2, 2008·Brain : a Journal of Neurology·Sean M NestorUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 21, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Mehul A TrivediSterling C Johnson
Dec 18, 2008·Expert Review of Neurotherapeutics·Carl A Gold, Andrew E Budson
Apr 28, 2009·Journal of the American Geriatrics Society·Andrea M WeinsteinKristine Yaffe
Aug 20, 2009·Current Alzheimer Research·Shannon L RisacherUNKNOWN Alzheimer's Disease Neuroimaging Initiative (ADNI)
Sep 18, 2009·European Radiology·Matthew C EvansUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 14, 2010·Neurobiology of Aging·Shannon L RisacherUNKNOWN Alzheimer's Disease Neuroimaging Initiative (ADNI)
Mar 23, 2011·Journal of Alzheimer's Disease : JAD·Sabine DerflingerMark Mühlau
Apr 8, 2011·Science Translational Medicine·David M HoltzmanAlison M Goate
Aug 5, 2011·PloS One·Yue CuiUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Dec 20, 2011·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Elkhonon GoldbergThomas Thesen
Feb 5, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Frank JessenUNKNOWN German Study on Aging, Cognition and Dementia in Primary Care Patients
Apr 26, 2013·Proceedings. Biological Sciences·Aida Gómez-RoblesChet C Sherwood
Aug 16, 2013·Clinical Interventions in Aging·Steven H Ferris, Martin Farlow
Oct 18, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Geoffrey A KerchnerBrian K Rutt
May 3, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kerstin J PlessenBradley S Peterson

❮ Previous
Next ❯

Citations

Nov 30, 2018·Frontiers in Aging Neuroscience·Nicola AmorosoSabina Tangaro
Dec 1, 2020·Journal of Alzheimer's Disease : JAD·Qingze ZengUNKNOWN The Alzheimer’s Disease Neuroimaging Initiative
Feb 3, 2021·Nature Communications·James M RoeUNKNOWN Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing
Aug 10, 2021·Journal of Alzheimer's Disease : JAD·Laurens Ansem van de MortelUNKNOWN Alzheimer’s Disease Neuroimaging Initiative

❮ Previous
Next ❯

Software Mentioned

fsaverage
_ Qdec
FreeSurfer
FreeSurfer fsaverage

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.